UBIO Stock Price, Chart, Stats & News
ProShares UltraPro Nasdaq Biotechnology (UBIO) does not currently pay a dividend.
UBIO chart
Price history is unavailable
We don't have enough price data for UBIO to draw a chart yet.
UBIO returns
| YTD | -45.67% |
| 1Y | -44.01% |
| 3Y | -12.20% |
| 5Y | 0.00% |
| 10Y | 0.00% |
| 1Y volatility | 74.03% |
| 3Y volatility | 65.95% |
| Sharpe ratio | 0.08 |
About
This fund aims to deliver daily returns equal to three times (3x) the daily movement of the NASDAQ Biotechnology Index, prior to accounting for fees and operating costs. To achieve this, it strategically deploys capital into various financial instruments, which ProShare Advisors expects will collectively mirror its ambitious daily performance target. The underlying index itself is a modified capitalization-weighted benchmark, comprising stocks of companies listed on Nasdaq that fall within the biotechnology or pharmaceutical sectors.
Similar securities
Based on sector and market capitalization
